Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis.

Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis.

Show other versions (1)

<h4>Background</h4>COVID-19 vaccination is essential. However, no study has reported adverse events (AEs) after ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease (ESRD) on hemodialysis (HD). This study investigated the AEs within 30-days after the first dose of ChAdOx1...

Full description

Bibliographic Details
Main Authors: I-Ning Yang, Chin-Li Lu, Hung-Jen Tang, Yu-Chi Kuo, Li-Hwa Tsai, Kuan Chieh Tu, Jhi-Joung Wang, Chih-Chiang Chien
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0273676

Internet

https://doi.org/10.1371/journal.pone.0273676

Similar Items